Arthur E. Schwarting Symposium LIVE Event 2026 – TBD

The Arthur E. Schwarting Symposium is an educational conference focused on pharmacy practice for pharmacists in many settings.

Arthur E. Schwarting Symposium 2026

Five hours of live CE

2025 Schwarting Agenda

11:00am-12:00 pm Information overload to action: Decoding academic concepts for pharmacy preceptors
Jennifer Luciano, PharmD, Director Office of Experiential Education, University of Connecticut School of Pharmacy, Storrs, CT

At the end of this presentation the learner will:

Discuss how ACPE standards, the NAPLEX blueprint, and Entrustable Professional Activities (EPAs) guide the development of clinical competence in students, specifically in the context of patient care.
Describe the Pharmacist Patient Care Process (PPCP) and its key components.
Explain how the PPCP framework is applied in experiential education and clinical rotations.

ACPE UAN: 0009-0000-25-026-L04-P Application

12:05-1:05 pm Patient Safety: Anticoagulation Stewardship: Identifying Key Data, Avoiding Errors, and Enhancing Safety
Youssef Bessada, PharmD, BCPS, BCPP, Assistant Clinical Professor,UConn School of Pharmacy, Storrs, CT

At the end of this presentation the learner will:

Differentiate high-priority, practice-changing information from less relevant or conflicting data after reviewing the anticoagulation guidelines, literature and clinical updates.
Recognize common anticoagulation-related errors in pharmacy practice and implement strategies to minimize patient safety risks
Identify red flag situations in anticoagulation management that pose patient safety risks.
Determine the appropriate guidelines or evidence-based resources to guide clinical decision-making and referrals

ACPE UAN: 0009-0000-25-029-L05-P Application

1:10-2:10 pm Information Overload in Chronic Coronary Disease
Michael White, PharmD, FCCP, FCP, BOT Distinguished Professor and Chair of Pharmacy Practice University of Connecticut School of Pharmacy, Storrs, CT

At the end of this presentation the learner will:

Determine if a patient has chronic cardiac disease (CCD).
Identify lifestyle modifications that can reduce the risk of CCD.
Identify therapies that can reduce final health outcomes for specific CCD patient types to design successful drug regimens.
Describe how the steps in the PPCP process can be applied when reviewing a cardiac patient.

ACPE UAN: 0009-0000-25-028-L01-P Application

2:15-3:15 pm Law: Understanding Disabled Pharmacy Patients’ Right to Nondiscrimination
Caroline Wick, JD, MSPH, BA, Practitioner-in-Residence and Acting Director of the Disability Rights Law Clinic, American University Washington College of Law, Washington DC

At the end of this presentation the learner will:

Describe the federal and state laws that protect patients with disabilities
Recognize situations in which accommodations should be provided to disabled patients
Recall examples of common modifications for patients with disabilities

ACPE UAN: 0009-0000-25-027-L03-P Knowledge

3:20-4:20 pm- So Much STI Data: Information to help you stay current and informed
Jennifer Girotto, PharmD, BCPPS, BCIDP, Associate Clinical Professor, UConn School of Pharmacy, Storrs, CT

At the end of this presentation the learner will

Describe updated screening recommendations and epidemiological trends of sexually transmitted infections (STIs).
Review the Centers for Disease Control and Prevention’s STIs recommendations.
Explain latest evidence based STI updates.
Given medication shortages, outline the pharmacist’s role in delivering targeted patient education and implementing strategies for responsible medication stewardship for STIs.

ACPE UAN: 0009-0000-25-030-L01-P Application

Handouts will be posted 72 hours prior to the event in 2 slide/page and 6 slide/page below:

11:00am-12:00 pm Information overload to action: Decoding academic concepts for pharmacy preceptors 2 slides/page
Information overload to action: Decoding academic concepts for pharmacy preceptors 6 slides/page

12:05-1:05 pm Patient Safety: Anticoagulation Stewardship: Identifying Key Data, Avoiding Errors, and Enhancing Safety 2 slides/page
Patient Safety: Anticoagulation Stewardship: Identifying Key Data, Avoiding Errors, and Enhancing Safety 6 slides/page

1:10-2:10 pm Information Overload in Chronic Coronary Disease – 2 slides/page
Information Overload in Chronic Coronary Disease – 6 slides/page

2:15-3:15 pm Law: Understanding Disabled Pharmacy Patients’ Right to Nondiscrimination 2 slides/page
Law: Understanding Disabled Pharmacy Patients’ Right to Nondiscrimination 6 slides/page

3:20-4:20 pm So Much STI Data: Information to help you stay current and informed – 2 slides/page
So Much STI Data: Information to help you stay current and informed – 6 slides/page

“The University of Connecticut School of Pharmacy is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education.”

Henry A. Palmer CE Finale LIVE Event Friday, Dec 13, 2024

Photograph of Henry A. Palmer

The School of Pharmacy Henry A. Palmer CE Finale, named for beloved professor and mentor, Dr. Henry A. Palmer, is a continuing education program offered at the end of each calendar year. Held during December, the program helps pharmacists fulfill their last minute CE requirements. The program is typically not a single theme, but an ala carte program offering a variety of presentations covering contemporary issues in pharmacy practice/therapeutics. Pharmacists may enroll in one or more [up to 8] hours of continuing education.

The University of Connecticut

School of Pharmacy

Presents the

Henry A. Palmer C.E. FINALE 2024

Aged to Perfection: Pharmacist Strategies for Elder Care Excellence

A LIVE (both virtual and in-person) application and knowledge-based continuing education activity for practicing pharmacists in all settings

Friday, December 13, 2024

7:30 AM – 5:00 PM Eastern Time
Sheraton Hartford South, Rocky Hill, CT

For a full course description see the Henry A. Palmer CE Finale Brochure 2024

REGISTRATION

Handouts for CE Finale will be available the first week of December

HANDOUTS FOR CE FINALE (these will be uploaded as available)

LAW: Medical-Legal Considerations of Aging Patients for Pharmacists-1 slide per page and clickable links

Law: Seniors Self-Diagnosing and Treating: A Brave (and scary) New World-6 per page
Law: Seniors Self-Diagnosing and Treating: A Brave (and scary) New World-2 per page

Balancing Safety and Efficacy: Addressing Medication Dilemmas in Older Adults -6 per page
Balancing Safety and Efficacy: Addressing Medication Dilemmas in Older Adults -2 per page

Immunization: Our Best Shot – Tips and Tools to Vaccinate Older Adults-6 per page
Immunization: Our Best Shot – Tips and Tools to Vaccinate Older Adults–2 per page

Opioids: Impact of Palliative Care on Total Pain in the Older Adult-6 per page
Opioids: Impact of Palliative Care on Total Pain in the Older Adult–2 per page

Patient Safety: Cheers to the Beers: Unpacking the Latest Updates for Safer Prescribing-6 per page
Patient Safety: Cheers to the Beers: Unpacking the Latest Updates for Safer Prescribing-2 per page

Beyond Memory Loss: Mastering the Management of Behavioral Symptoms in Dementia– 6 per page
Beyond Memory Loss: Mastering the Management of Behavioral Symptoms in Dementia–2 per page

LAW: Call 1-800-Get-Cash Fast: Drug-Related Advertisements about Litigation-6 per page
LAW: Call 1-800-Get-Cash Fast: Drug-Related Advertisements about Litigation-2 per page

CE FINALE SCHEDULE/TOPICS/LEARNING OBJECTIVES

7:30-8:00 a.m. – Registration and Check-In/Sign-In

8:00-8:05 a.m. – Opening Remarks- Philip Hritcko, Dean, School of Pharmacy

8:05-8:10 a.m. – Operational Instructions-Jeannette Y. Wick, Dir. OPPD

8:10-9:10 a.m. – LAW: Medical-Legal Considerations of Aging Patients for Pharmacists
Jennifer A. Osowiecki, RPh, JD, Cox & Osowiecki, LLC, Hartford, CT

At the conclusion of this presentation, pharmacists will be able to:

1. List at least three common medical-legal concerns associated with aging.

2. Identify what constitutes elderly abuse or neglect and describe whether the pharmacist has a reporting obligation.

3. Discuss the likelihood of polypharmacy and measures that pharmacists can employ to facilitate better medication management and compliance for elderly patients and their caregivers.

0009-0000-24-042-L03-P (0.1 CEU or 1 contact hour) (Application-based)

9:15-10:15 a.m. Law: Seniors Self-Diagnosing and Treating: A Brave (and scary) New World

Michael White, PharmD, FCCP, FCP, BOT Distinguished Professor and Chair of Pharmacy Practice, University of Connecticut School of Pharmacy, Storrs, CT

At the conclusion of this presentation, pharmacists will be able to:

Describe the reasons seniors are increasingly diagnosing and treating themselves with therapies
Describe the legal and regulatory pathways that provide seniors access to therapies outside the drug supply chain
Describe the ways that pharmacists can recommend dietary supplements that are free of adulterants and contaminants
Describe the risks associated with self-treatment with dietary supplements, “peptides”, and counterfeit drugs

0009-0000-24-044-L03-P (0.1 CEU or 1 contact hour) (Knowledge-based)

10:20-11:20 a.m. – Balancing Safety and Efficacy: Addressing Medication Dilemmas in Older Adults

Christina Polomoff, PharmD, BCACP, BCGP, FASCP, Population Health Clinical Pharmacist, Associate Clinical Professor, University of Connecticut School of Pharmacy, Storrs, CT

At the conclusion of this presentation, pharmacists will be able to:

Analyze pharmacokinetic and pharmacodynamic changes associated with aging
Identify opportunities for deprescribing and medication management
Use evidence-based tools and strategies to optimize medication regimens, applying deprescribing frameworks and decision aids in real-world geriatric care

0009-0000-24-043-L01-P (0.1 CEU or 1 contact hour) (Application-based)

11:25-12:25 p.m. – Immunization: Our Best Shot – Tips and Tools to Vaccinate Older Adults

At the conclusion of this presentation, pharmacists will be able to

1. RECOGNIZE appropriate vaccine recommendations for the older adult population

2. IDENTIFY potential barriers to vaccinations

3. ANALYZE current methods used to improve vaccination rates

4. DISCUSS ways to improve vaccine compliance in your patient population

0009-0000-24-047-L06-P (0.1 CEU or 1 contact hour) (Application-based)

12:25-12:45 p.m. – BREAK-light snacks will be served.

12:45-1:45 p.m. – Opioids: Impact of Palliative Care on Total Pain in the Older Adult

Megan Mitchell, PharmD, MS, Pharmacy Clinical Coordinator Pain Management and Palliative Care, University of Connecticut Healthcare, Farmington, CT

At the conclusion of this presentation, pharmacists will be able to:

Describe Palliative Care and its importance in the healthcare system today
Define the concept of “total pain” and the importance of whole person care in pain and symptom management
Recognize the physiologic changes that occur with aging and how those impact pain and symptom management
Determine the role of the pharmacist in total pain management in the older adult

0009-0000-24-046-L08-P (0.1 CEU or 1 contact hour) (Application-based)

1:50-2:50 p.m. –Patient Safety: Cheers to the Beers: Unpacking the Latest Updates for Safer Prescribing
Kelsey Giara, PharmD, Freelance Medical Writer, Pelham, NH

At the conclusion of this presentation, pharmacists will be able to:

Review the role of the Beers Criteria in reducing potentially inappropriate medication (PIM) use and enhancing patient safety in older adults
Identify recent updates to the Beers Criteria and their implications for medication management in geriatric care
Apply the updated Beers Criteria to real-world scenarios, optimizing medication selection and minimizing risks in older adult

0009-0000-24-045-L05-P (0.1 CEU or 1 contact hour (application-based)

2:55-3:55 p.m. – Beyond Memory Loss: Mastering the Management of Behavioral Symptoms in Dementia

Kristin Waters, PharmD, BCPS, BCPP, Assistant Clinical Professor, UConn School of Pharmacy, Storrs, CT

At the conclusion of this presentation, pharmacists will be able to:

Identify clinical characteristics of the behavioral symptoms of dementia (BSD) including agitation, psychosis, and sleep disturbances
Discuss medications currently used in the management of BSD along with emerging pharmacologic therapy options
Determine the most appropriate pharmacologic treatment option for a patient with behavioral symptoms of dementia based on patient-specific factors

0009-0000-24-048-L01-P (0.1 CEU or 1 contact hour) (Application-based)

4:00-5:00 p.m. –LAW: Call 1-800-Get-Cash Fast: Drug-Related Advertisements about Litigation
Jeannette Y. Wick, RPh, MBA, Director Office of Professional Pharmacy Development, UConn School of Pharmacy, Storrs, CT

At the conclusion of this presentation, pharmacists will be able to:

Explain common terminology associated with commercials targeting older Americans
Describe legal processes associated with lawsuits generated against companies that make products alleged to cause harm
Discuss generalities in potential lawsuits associated with media promotion campaigns
Identify areas where no information is available to provide good, valid answers for patients who ask questions

0009-0000-24-049-L03-P (0.1 CEU or 1 contact hour) (Application-based)

CE FINALE ENCORE WEBINARS AVAILABLE

If you find you cannot make it to our LIVE EVENT on Friday, December 13^th, you can participate in our ENCORE LIVE WEBINARS that will be streamed on the following dates:

Monday, December 16, 12:00 (Noon) – 1:00 pm – Seniors Self-Diagnosing and Treating: A Brave (and scary) New World
Monday, December 16, 7:00 pm – 8:00 pm – Patient Safety: Cheers to the Beers: Unpacking the Latest Updates for Safer Prescribing
Monday, December 16, 8:10 pm – 9:10 pm – Immunization: Our Best Shot – Tips and Tools to Vaccinate Older Adults
Tuesday, December 17, 12:00 (Noon) – 1:00 pm – Opioids: Impact of Palliative Care on Total Pain in the Older Adult
Tuesday, December 17, 7:00 pm-8:00 pm – LAW: Call 1-800-Get-Cash Fast: Drug-Related Advertisements about Litigation
Wednesday, December 18, 12:00 pm-1:00 pm – Beyond Memory Loss: Mastering the Management of Behavioral Symptoms in Dementia

Registration Information

Online: https://ce.pharmacy.uconn.edu/henry-a-palmer-ce-finale/

A continuous class schedule format will be used. This format does not include breaks but does include a 20 minute lunch period.

Refunds and Cancellations: The registration fee, less a $75 processing fee, is refundable for those who cancel their registration three (3) days prior to the program (by December 10) After that time, no refund is available.

Location: The Henry A. Palmer C.E. Finale will be held both virtually or in-person. You must sign in to the Webex link at the designated time using the link in your confirmation email if you decide to participate virtually.

Continuing Education Units

The University of Connecticut, School of Pharmacy, is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education. Statements of Credit will be awarded at CE Finale based on full sessions attended and completed online evaluations. Pharmacists can earn up to 8 contact hours (0.80 CEU) three of which are Law credits, and one is an Immunization credit, one is a Patient Safety credit and one is an Opioid credit.

Please Note: Pharmacists who wish to receive credit for the presentations MUST ACCURATELY complete the registration and online evaluations within 45 days of the live program (January 27, 2025). Participants are accountable for their own continuing education requirements for license renewal and are required to follow up with joanne.nault@uconn.edu to resolve a discrepancy in a timely manner. PLEASE CHECK YOUR CPE MONITOR PROFILE within 3 days of submission to assure that your credits have been properly uploaded. Requests for exceptions will be handled on a case-by-case basis and may result in denial of credit.

Activity Support: There is no funding for this program.

Long-Acting Injectable Medication Products

Pharmacists possess the training and skills necessary to administer certain long-acting injectable (LAI) medications used in the management of mental illnesses and substance use disorders. Through collaborative practice agreements, pharmacists can administer Long Acting Injectables in almost every state. In some states, including the state of Connecticut, this occurs via collaborative agreements, and necessary injection and disease state training. Administration of these medications by pharmacists can increase accessibility of care for patients.

UConn has developed web-based continuing pharmacy education activity to enhance pharmacists’ skills and help them make sound clinical decisions about long acting injectables administration. This course includes eight hours of CPE (or eight hours of credit), required by the State of Connecticut. Successful completion of these eight hours (with four activities consisting of three hours online pre-requisite work and five hours of LIVE CE) will earn the pharmacist a Certificate in Long-Acting Injectables of Psychotropic Medication.

The three activities below are available separately for $17/hour each, or as pre-requisites for the entire Long-Acting Injectable Psychotropic Medication Pharmacist Certificate Training Program at $299 which includes both the prerequisites and the full day of LIVE training.

At the end of this application-based continuing education activity, the learner will be able to:

Compare and contrast among different long-acting injectable (LAI) medications currently available for the

treatment of schizophrenia, bipolar disorder and substance use disorders including:

· Dosing

· Generic and brand names

· Adverse effects

· Administration schedule

· Overlap with oral medications

· FDA-approved indications

If desired, pharmacists can register for the entire Long-Acting Injectable Psychotropic Medication Pharmacist Certificate Training Program

or for the individual activities. The Certificate consists of three activities in our online selection, and a 5 hour LIVE activity.

You may register for individual topics at $17/CE Credit Hour, or for the Entire LAIA Certificate at $299.00 which includes 5 hours of LIVE CE and the 3 online pre-requisites listed below.

You must register for ALL 4 activities to receive the bundled pricing of $299.00

In accordance with the Accreditation Council for Pharmacy Education (ACPE) Criteria for Quality and Interpretive Guidelines, The University of Connecticut School of Pharmacy requires that faculty disclose any relationship that the faculty may have with commercial entities whose products or services may be mentioned in the activity.

Dr. Waters is a consultant with Janssen Pharmaceuticals. She will discuss all drugs without bias. All financial interests with ineligible companies (as noted) have been mitigated.

Guideline-Driven Treatment for Mental Illnesses and Substance Abuse Disorders

At the end of this application-based continuing education activity, the learner will be able to:

Describe first- and second-line treatment options for the following disease states:

· Schizophrenia

· Bipolar disorder

· Alcohol use disorder

· Opioid use disorder

Identify where long-acting injectable medications fit into treatment guidelines for each disorder

Apply clinical treatment guidelines to select optimal pharmacologic treatment for a patient diagnosed with these disorders

If desired, pharmacists can register for the entire Long-Acting Injectable Psychotropic Medication Pharmacist Certificate Training Program

or for the individual activities. The Certificate consists of three activities in our online selection, and a 5 hour LIVE activity.

You may register for individual topics at $17/CE Credit Hour, or for the Entire LAIA Certificate at $299.00 which includes 5 hours of LIVE CE and the 3 online pre-requisites listed below.

You must register for ALL 4 activities to receive the bundled pricing of $299.00

Dr. Waters is a consultant with Janssen Pharmaceuticals. She will discuss all drugs without bias. All financial interests with ineligible companies (as noted) have been mitigated.

Mental Illness and Substance Use Disorders: Background

If desired, pharmacists can register for the entire Long-Acting Injectable Psychotropic Medication Pharmacist Certificate Training Program

or for the individual activities. The Certificate consists of three activities in our online selection, and a 5 hour LIVE activity.

You may register for individual topics at $17/CE Credit Hour, or for the Entire LAIA Certificate at $299.00 which includes 5 hours of LIVE CE and the 3 online pre-requisites listed below.

You must register for ALL 4 activities to receive the bundled pricing of $299.00

Dr. Waters is a consultant with Janssen Pharmaceuticals. She will discuss all drugs without bias. All financial interests with ineligible companies (as noted) have been mitigated.

Hour 1: Mental Illness and Substance Use Disorders: Background

1. A 38-year-old patient with an unknown psychiatric history is dropped off at the emergency department by police after being found wandering the streets and knocking on doors at random. The patient admits that they believe they are being monitored by the FBI and that “the mafia” wants to recruit them as a spy. The patient is observed having a conversation with themselves while alone in the examination room.

Which of the following positive symptoms is the patient likely experiencing?
A. Psychosis and auditory hallucinations
B. Auditory hallucinations and delusions
C. Delusions and anhedonia
D. Paranoia and agitation

2. Which of the following is the correct term for fixed, false beliefs that patients with schizophrenia may experience?
A. Delusions
B. Hallucinations
C. Disorganized speech
D. Catatonia

3. A patient with schizophrenia has experienced both positive and negative symptoms for several years. They are now presenting with signs of mania, including pressured speech and grandiosity. Which of the following is true?
A. The patient’s diagnosis will likely change to schizoaffective disorder, bipolar type
B. The patient’s diagnosis will likely change to schizoaffective disorder, depressive type
C. The patient will now be diagnosed with schizophrenia and bipolar disorder
D. The patient will now be diagnosed with schizophrenia and major depressive disorder

4. Which of the following is true about bipolar disorder?
A. The most common time that patients are diagnosed is during childhood
B. Most patients are initially diagnosed with schizophrenia
C. It has a higher mortality rate than major depressive disorder
D. Type II bipolar disorder is associated with more severe episodes of mania than type I

5. Most patients with bipolar disorder spend the majority of their time in which mood phase?
A. Mania
B. Depression
C. Hypomania
D. Euthymia

6. A patient with bipolar disorder presents to their outpatient provider and reports that they believe they are on the verge of a “breakthrough” and will soon become a world-famous author once their manuscript is published. They have recently stopped going to work and have been writing “all day and all night” for the past week. They also report spending thousands of dollars on a new computer so that they have “the best equipment” with which to write their manuscript.
Which of the following symptoms of mania is the patient displaying?
A. Grandiosity, decreased need for sleep, increased goal directed activity
B. Flight of ideas, distractibility, grandiosity
C. Disorganized thoughts, decreased need for sleep, flight of ideas
D. Confusion, excessive spending, distractibility

7. Patient NP was diagnosed with bipolar disorder, type II approximately 5 years ago. They have rarely missed work due to hypomanic symptoms, and are generally able to perform all day-to-day activities without impairment. Following a breakup, NP begins to display signs of grandiosity, flight of ideas, decreased sleep, and increased spending. They also begin to hear the voice of their ex-partner telling them that they are worthless.

Which of the following is most appropriate?
A. NP’s diagnosis should be changed to bipolar disorder type I
B. NP’s diagnosis should remain the same
C. NP’s diagnosis should be changed to schizoaffective disorder
D. NP’s diagnosis should be changed to bipolar disorder, mixed type

8. Which of the following is a risk factor for the development of a substance use disorder?
A. Female gender
B. Age > 65 years
C. Co-occurring psychiatric disorder
D. Parenthood

9. Which type of opioid receptor contributes to the stimulation of the dopamine-related reward system?
A. Mu-opioid receptor
B. Kappa-opioid receptor
C. Delta-opioid receptor
D. Beta-opioid receptors

Anticoagulation Traineeship – Certificate Program

The University of Connecticut School of Pharmacy and The UConn Health Center Outpatient Anticoagulation Clinic have developed 2-day practice-based ACPE certificate continuing education activity for registered pharmacists and nurses who are interested in the clinical management of patients on anticoagulant therapy and/or who are looking to expand their practice to involve patient management of outpatient anticoagulation therapy. This traineeship will provide you with both the clinical and administrative aspects of a pharmacist-managed outpatient anticoagulation clinic. The activity features ample time to individualize your learning experience. A “Certificate of Completion” will be awarded upon successful completion of the traineeship.

“I had a very successful and wonderful learning experience that I will treasure and WILL apply to my practice ASAP” – LKD

“ ….this is a great program and I do not have enough good things to say about Dr. Durman and Dr. Bui. They have amalgamated the art of customer service and patient care and have integrated my traineeship into their routine without any issues. ” – LP

“.….very comprehensive 2 days. I was able to see a lot!” – MS

Target Audience

This certificate program is for registered pharmacists and nurses who are interested in the clinical management of patients on anticoagulant therapy and/or who are looking to expand their practice to involve patient management of outpatient anticoagulation therapy.

Traineeship Learning Objectives

At the conclusion of the 2 day traineeship, pharmacists will be able to:

Conduct patients interviews
Evaluate current medications as it relates to anticoagulation therapy
Describe the proper technique for obtaining point-of- care INR testing
Adjust anticoagulant therapy for a patient based on desired outcome
Prepare a patient-specific monitoring plan
Formulate a note for the patient’s chart outlining your assessment and plan
Describe how to bill for services

Pre-Requisites

All participants must successfully complete the 12-hour online training at pharmacy.uconn.edu/academics/ce/anticoagul ation or an equivalent training as approved by the Director of CE and the faculty of the traineeship.
All participants must have a valid pharmacist, MD or nursing license
All participants must provide documentation of current professional liability insurance
All participants must complete the application (below)
A telephone interview will be conducted prior to day 1 to discuss goals and expectations of the A copy of clinic’s policy and procedures will also be forwarded to the participant prior to the visit. Participants are expected to be familiar with the clinic’s policy and point-of-care testing manual.

Location

UConn Health Outpatient Services Anticoagulation Clinic
11 SOUTH ROAD
FARMINGTON, CT 06030
Suite 230 MC 6237

Email your completed application and proof of liability insurance to joanne.nault@uconn.edu. Once received, UConn will contact you with the date of attendance.

Summer 2025 dates!

Tuesday and Wednesday, June 24 & 25

Tuesday and Wednesday, July 15 & 16

Tuesday and Wednesday, September 16 & 17

Agenda for Traineeship

Day 1
8:30-9:00 am	Orientation to the clinic and staff, HR forms, review clinic workflow
9:00 am-12:30 pm	Observation of patient interview process, point-of-care testing, dose decision making, and documentation procedures.
12:30 pm-1:00 pm	Lunch
1:00 pm-3:00 pm	Observed patient interviews and documentation
3:00 pm-3:30 pm	Observed telephone patient interviews, and documentation
3:30 pm-4:30 pm	Day 1 review and evaluation
Day2
8:30 am-9:00 am	Q/A in preparation for day’s work
9:00 am-12:30 pm	Solo telephone patient interviews, and documentation.
12:30 pm -1:00 pm	Lunch
1:00 pm-1:30 pm	Review of morning’s work
1:30 pm-2:30 pm	Solo patient interviews, and documentation.
2:30 pm-4:30 pm	Wrap up Q/A, address individual needs and final evaluation.

Activity Faculty

Anuja Rizal, RPh, PharmD, CACP, John Dempsey Hospital Anticoagulation Clinic Coordinator, Farmington, CT

Elizabeth Biron, PharmD, John Dempsey Hospital Anticoagulation Clinic Pharmacist, Farmington, CT

Damian Green, Pharmacy Technician, John Dempsey Hospital Anticoagulation Clinic, Farmington, CT

Faculty Disclosure

Dr. Rizal does not have anything to disclose.

Dr. Biron does not have anything to disclose.

Activity Fees

Prerequisite Online content: can be found at www.pharmacy.uconn.edu/academics/ce/anticoagulation click on each of the listed activities to register. If you register for the entire bundle, the pricing is discounted to $140 total rather than approximately $17/credit hour.

Live content: Please see above for available traineeship dates. These dates are filled on a first come/first serve basis.

The Registration Fee of $500 includes all costs of the traineeship instruction and printed materials, but does not include the home study pre-requisites.

APPLICATION

Please call Joanne or Heather at 860-486-2084 with credit card information. Scan and email your completed application to the address below.

heather.kleven@uconn.edu

There is no reduced fee for UConn faculty, adjunct faculty, preceptors or volunteers for this program

Refunds

The registration fee, less a $75 processing fee, is refundable for those that cancel their registration more than 14 days prior to your scheduled live program. After that time, no refund is available. Participant substitutions may be made at any time.

Grant Funding

There is no grant funding for this activity.

The University of Connecticut, School of Pharmacy, is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education. Sixteen contact hours (1.6 CEU’s) of practice-based certificate continuing education credit for pharmacists who participate in the traineeship and pass the competency evaluation with at least a “3” in all of the assessment categories. Credit will be automatically uploaded to the CPE Monitor system, and a certificate of completion will be mailed within 4 weeks of traineeship completion. UAN#0009-0000-23-003-L01-P

Initial release date: March 16, 2023
Planned expiration date: March 16, 2026

Disclaimer:
The material presented here does not necessarily reflect the views of The University of Connecticut School of Pharmacy or its co-sponsor affiliates. These materials may discuss uses and dosages for therapeutic products, processes, procedures and inferred diagnoses that have not been approved by the United States Food and Drug Administration. A qualified health care professional should be consulted before using any therapeutic product discussed. All readers and continuing education participants should verify all information and data before treating patients or employing any therapies described in this continuing education activity.

About this Course

Target Audience

Pharmacist Learning Objectives

Bundle Options

Accreditation Statement

Grant Funding

Requirements for Successful Completion

Faculty

Faculty Disclosure

Disclaimer

Program Content

Program Handouts

Post Test Evaluation

View Questions for Long-Acting Injectable Medication Products

Additional Courses Available for Long Acting Injectable Training

About this Course

Target Audience

Pharmacist Learning Objectives

Bundle Options

Accreditation Statement

Grant Funding

Requirements for Successful Completion

Faculty

Faculty Disclosure

Disclaimer

Program Content

Program Handouts

Post Test Evaluation

View Questions for Mental Illness and Substance Use Disorders: Background

Additional Courses Available for Long Acting Injectable Training

About this Course

Target Audience

Pharmacist Learning Objectives

Bundle Options

Accreditation Statement

Grant Funding

Requirements for Successful Completion

Faculty

Faculty Disclosure

Disclaimer

Program Content

Program Handouts

Post Test Evaluation

View Questions for Mental Illness and Substance Use Disorders: Background

Additional Courses Available for Long Acting Injectable Training

Target Audience

Traineeship Learning Objectives

Pre-Requisites

Location

Agenda for Traineeship

Activity Faculty

Faculty Disclosure

Activity Fees

The Registration Fee of $500 includes all costs of the traineeship instruction and printed materials, but does not include the home study pre-requisites.

Refunds

Grant Funding